Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
Taro Kishi,1,* Shinji Matsunaga,1,2,* Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan; 2Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan *These authors c...
Saved in:
Main Authors: | Kishi T, Matsunaga S, Iwata N |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/3ec67a78498f4e618110e3ad6effe6c1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
by: Kishi T, et al.
Published: (2017) -
Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
by: Stuart J Thomas, et al.
Published: (2009) -
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
by: Wade AG, et al.
Published: (2014) -
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
by: Kishi T, et al.
Published: (2017) -
Memantine for the treatment of frontotemporal dementia: a meta-analysis
by: Kishi T, et al.
Published: (2015)